RNS Number:1917L
Gyrus Group PLC
16 May 2003

16th May 2003





                                Gyrus Group PLC

                         Board Appointments and Changes





Gyrus Group PLC today announces changes to the structure of the Company's Board
of Directors in order to improve the Company's governance and management
processes.  The changes announced today, which include the appointment of two
new non-executive Directors, will take effect from the conclusion of the
Company's AGM on 22 May 2003.



Gyrus is pleased to appoint both Professor Charles Cummings MD, a widely
respected expert in ear, nose and throat surgery, and Keith Krzywicki, Managing
Director of Pharmacia Limited, to the Board.



Professor Cummings has been Director of the Department of Otolaryngology - Head
and Neck Surgery at Johns Hopkins since 1990.  Prior to that, he spent twelve
years as Chairman of the Department of Otolaryngology at the University of
Washington.  He has written over 125 scientific papers and has served as a
Director of the American Board of Otolaryngology.  He is a past president of the
American Academy of Otolaryngology Head and Neck Surgery, the American Society
for Head and Neck Surgery and the American Association for Academic Departments
of Otolaryngology, and has a broad understanding of the issues that effect the
US healthcare sector.



Keith Krzywicki has been Managing Director of Pharmacia Limited since 2000 where
he is responsible for the Prescription Pharmaceutical Business.  Prior to his
current role, he was President of Pharmacia & Upjohn UK and Ireland for five
years.  From 1990 to 1995, he was Managing Director of Upjohn Ltd, UK and
Ireland and before that held various positions at Upjohn across Europe.



Gyrus also announces that, from the conclusion of the AGM on 22 May 2003, Chris
Smith, Colin Goble and Jon Moore will relinquish their roles as directors of
Gyrus Group PLC and become key members of the newly-formed operations board of
the company.  The Board believes that the separation of the operations board,
which will focus on day-to-day business issues, from the Board of Directors will
sharpen management focus on operational matters and allow the Board of
Directors, which will now be predominantly comprised of independent
non-executive directors, to focus on strategic and corporate governance matters
as well as monitoring the performance of the Group.  Accordingly, in view of the
re-organisation of the Board, resolution 4 of the AGM proposing the
reappointment of Mr Colin Goble as a director will be withdrawn.



Mr Michael Garner, currently senior non-executive director, is appointed Deputy
Chairman with effect from 22 May 2003.  Three executive directors, Brian Steer
(Chairman), Dr Mark Goble (Group Managing Director) and Tom Murphy (Group
Finance Director) remain on the Board of Directors and will provide strong
executive representation.



The Board is also pleased to announce that it has been agreed that Brian Steer's
service contract will be extended for a further year to July 2005. Under the
terms of the service agreement, Mr Steer's contract can be terminated by either
party giving six months notice.



Brian Steer, Chairman, said: "We welcome Professor Charles Cummings and Keith
Krzywicki to the Board.  We believe that their substantial experience will be of
great value to Gyrus as we enter the next phase of the Company's development.
We also believe that the formation of the new operations board will sharpen
management focus and improve our operational efficiency."



The following additional information is disclosed in accordance with Chapter 16
of the Listing Rules regarding Professor Charles Cummings and Keith Krzywicki:

1.      There are no details to be disclosed under paragraph 16.4 (a)

2.      There are no details to be disclosed under paragraph 6.F.2 (b) to (g)

3.      Professor Charles Cummings holds 1200 ordinary 1p shares in Gyrus Group
        PLC.

4.   Keith Krzywicki holds no shares in Gyrus Group PLC.



Enquiries:


Gyrus Group PLC

Mark Goble, Managing Director                                Tel: 01189 219 720
                                            
Tom Murphy, Finance Director

Financial Dynamics                                           Tel: 0207 831 3113

Ben Atwell








                      This information is provided by RNS
            The company news service from the London Stock Exchange
END

MSCGUUPPAUPWGUQ